BRIDGEWATER, N.J. — Valeant Pharmaceuticals International Inc., has signed a long-term, 310,000-square-foot lease to completely occupy Somerset Corporate Center IV in Bridgewater. The facility is located within SJP Properties’ 2.1 million-square-foot, Class A office complex, about 30 miles southwest of Newark. Valeant, a multinational pharmaceutical company, will consolidate multiple locations into its new U.S. headquarters at the office complex. The company is expected to relocate to Somerset Corporate Center IV starting in the first quarter of 2014. SJP Properties will oversee the build-out of its new headquarters. Amenities at the building include a full-service cafeteria, a conference center with a 225-seat, theater-style auditorium and a fitness center. Greg Ficke, director, David Sherman, executive vice president, and Harlan Hollander, senior director at Cushman & Wakefield, represented Valeant in the transaction. Jeff Schotz, executive vice president, and Peter Bronsnick, senior vice president, represented SJP in house.
45